Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends
Deep-pocketed investors have adopted a bullish approach towards Regeneron Pharmaceuticals REGN, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The …